Copyright
©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3158-3166
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3158
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3158
Figure 1 Receiver operating characteristic curve of serum ubiquitin carboxy-terminal hydrolase L1 and glial fibrillary acidic protein levels for predicting postoperative recurrence of glioma.
UCH-L1: Ubiquitin carboxy-terminal hydrolase L1; GFAP: Glial fibrillary acidic protein.
- Citation: Zhu QH, Wu JK, Hou GL. Changes and significance of serum ubiquitin carboxyl-terminal hydrolase L1 and glial fibrillary acidic protein in patients with glioma. World J Clin Cases 2023; 11(14): 3158-3166
- URL: https://www.wjgnet.com/2307-8960/full/v11/i14/3158.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i14.3158